NYSE · KVUE
Kenvue Inc.
$19.28 +$0.38 (+2.01%) 1D After hours
Session Pulse
Overnight session
1
mentions on Fri
· 1 bullish
/ 0 bearish tags
No new SEC filings since Mon close
its sector ranked
4/11
this week
Full pulse →
Key Metrics
$36.29B
Market cap
22.37×
P/E · TTM
$15.29B
Revenue · TTM
$1.62B
Net income
EPS · TTM
$0.84
Dividend yield
4.4%
Free cash flow
$1.82B
Beta · 1Y
0.15
EBITDA · TTM
$3.19B
Gross margin
58.4%
Snapshot
Market cap$36.29B
Enterprise value$36.80B
Shares outstanding1.9B
52-wk range$14.02 – $22.74
Avg volume · 20D23.2M
Net cash
−$511.00M
Book value / share$5.51
IndustryPerfumes, Cosmetics & Other Toilet Preparations
ExchangeNYSE
About Kenvue Inc.
IPO dateMay 4, 2023
Employees22000
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E22.37
P/S2.37
P/FCF19.91
EV/EBITDA11.55
EV/Sales2.41
Graham №$10.22
Profitability
Gross
58.4%
Operating
17.2%
Net
10.6%
FCF
11.9%
ROE / ROIC
16.0% · 17.3%
Financial Health
Current ratio0.98
Quick ratio0.70
Debt / equity0.15
Debt / EBITDA
0.50Low leverage
Net cash
−$511.00M
Working capital−$101.00M
Cash Flow · TTM
Operating CF
$2.26B
Capex
−$435.00M
Free cash flow
$1.82B
Buybacks
$134.00M
Dividends paid
$1.59B
Shareholder yield
4.7%
Piotroski F-Score
5 / 9
Middling fundamentals · 5 of 9 signals passing
Altman Z-Score
2.2
Grey zone (1.81–2.99) · monitor
Graham Number vs Price
$10.22 vs $19.28
Trades 1.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-29 · computed by TickerWolf from SEC filings